posted
These topics are so funny. Everyone just posts what they're in on. What they're hoping will gap. Unfortunately, if you look at these past "Gappers" threads, I'm sure you'll see that 98% of them didn't do anything! Good luck... Oh by the way... Gappers for tomorrow are GZFX, SVXP, & FCDH!!! WOO HOOO!!!
IP: Logged |
posted
kilerb our plays are the same and I hope they all gap and run, but seriously SVXP might be a gapper with the kind of movement we have seen today.
IP: Logged |
CytoGenix and GE Healthcare Ink BioDefense Support Agreement Tuesday December 27, 4:18 pm ET
HOUSTON--(BUSINESS WIRE)--Dec. 27, 2005--CytoGenix, Inc. (OTCBB:CYGX - News) announced today the signing of a contract with the Fast Trak BioDefense group of GE Healthcare, a unit of General Electric Company (NYSE:GE - News).
GE Healthcare's Fast Trak BioDefense group has a diverse staff of highly qualified technical and regulatory experts who will collaborate with CytoGenix in seeking, obtaining and executing bio-defense related federal contracts.
Frank Vazquez, CytoGenix, Inc. Executive Vice President and COO commented, "Our association with GE Healthcare, a $14 Billion entity of GE, as partners in competing for federal research projects sends a very positive message to grant reviewers and granting agencies at the Department of Homeland Security, the Department of Defense and the Department of Health and Human Services. We are very excited about this relationship and expect to see very positive results soon."
Dr. Sandy Weinberg, Senior Director, Fast Trak BioDefense GE Healthcare commented, "CytoGenix's innovative DNA vaccine and antimicrobial technology can be applied to many critical needs in bio-defense. The company has an excellent team of scientists, and we expect with that with our assistance we can attain substantial results."
About GE Healthcare: GE Healthcare is a $14 billion unit of General Electric Company (NYSE:GE - News) that is headquartered in the United Kingdom. Worldwide, GE Healthcare employs more than 42,500 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit the company's website at www.gehealthcare.com.
About CytoGenix: CytoGenix, Inc. is a Houston-based biopharmaceutical company that develops and markets innovative products and services based on its proprietary ssDNA expression technology. The company has developed a breakthrough synthetic process for large-scale production of high purity DNA at a fraction of the cost of traditional fermentation methods. CytoGenix currently has one issued US patent and 41 international or US pending patent applications claiming methods and materials in connection with this platform technology.
SAFE HARBOR: Except for statements of historical fact, the statements in this press release are forward-looking. Such statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include, but are not limited to, general economic conditions, risks associated with the acceptance of new products, competition, and other factors more fully detailed in the company's filings with the Securities and Exchange Commission.
Additional information about CytoGenix and its technology can be found on the website at www.cytogenix.com.
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
Good luck... Oh by the way... Gappers for tomorrow are GZFX, SVXP, & FCDH!!! WOO HOOO!!!
